These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 6339403)

  • 1. Ascending, unobstructed urinary tract infection in mice caused by pyelonephritogenic Escherichia coli of human origin.
    Hagberg L; Engberg I; Freter R; Lam J; Olling S; Svanborg Edén C
    Infect Immun; 1983 Apr; 40(1):273-83. PubMed ID: 6339403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of adhesion to bacterial persistence in the mouse urinary tract.
    Hagberg L; Hull R; Hull S; Falkow S; Freter R; Svanborg Edén C
    Infect Immun; 1983 Apr; 40(1):265-72. PubMed ID: 6131870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histopathologic-microbiologic correlates of invasiveness in a mouse model of ascending unobstructed urinary tract infection.
    Johnson JR; Berggren T; Manivel JC
    J Infect Dis; 1992 Feb; 165(2):299-305. PubMed ID: 1730896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation of the gene encoding cytotoxic necrotizing factor type 1 (cnf(1)) attenuates the virulence of uropathogenic Escherichia coli.
    Rippere-Lampe KE; O'Brien AD; Conran R; Lockman HA
    Infect Immun; 2001 Jun; 69(6):3954-64. PubMed ID: 11349064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isogenic P-fimbrial deletion mutants of pyelonephritogenic Escherichia coli: the role of alpha Gal(1-4) beta Gal binding in virulence of a wild-type strain.
    Mobley HL; Jarvis KG; Elwood JP; Whittle DI; Lockatell CV; Russell RG; Johnson DE; Donnenberg MS; Warren JW
    Mol Microbiol; 1993 Oct; 10(1):143-55. PubMed ID: 7968511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxic Necrotizing Factor-1 (CNF1) does not promote E. coli infection in a murine model of ascending pyelonephritis.
    Michaud JE; Kim KS; Harty W; Kasprenski M; Wang MH
    BMC Microbiol; 2017 May; 17(1):127. PubMed ID: 28545489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent progress in the understanding of the role of bacterial adhesion in the pathogenesis of urinary tract infection.
    Svanborg Edén C; Hagberg L; Leffler H; Lomberg H
    Infection; 1982; 10(5):327-32. PubMed ID: 6129198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of uropathogenic Escherichia coli metapopulation movement during urinary tract infection.
    Walters MS; Lane MC; Vigil PD; Smith SN; Walk ST; Mobley HL
    mBio; 2012; 3(1):. PubMed ID: 22318320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophil recruitment and resistance to urinary tract infection.
    Haraoka M; Hang L; Frendéus B; Godaly G; Burdick M; Strieter R; Svanborg C
    J Infect Dis; 1999 Oct; 180(4):1220-9. PubMed ID: 10479151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vesicoureteral reflux induces renal trauma in a mouse model of ascending, unobstructed pyelonephritis.
    Johnson JR; Manivel JC
    J Urol; 1991 Jun; 145(6):1306-11. PubMed ID: 2033721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PapG II adhesin in the establishment and persistence of Escherichia coli infection in mouse kidneys.
    Tseng CC; Huang JJ; Wang MC; Wu AB; Ko WC; Chen WC; Wu JJ
    Kidney Int; 2007 Apr; 71(8):764-70. PubMed ID: 17290293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacterial virulence versus host resistance in the urinary tracts of mice.
    Svanborg-Edén C; Hagberg L; Hull R; Hull S; Magnusson KE; Ohman L
    Infect Immun; 1987 May; 55(5):1224-32. PubMed ID: 3552994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship among bacterial virulence, bladder dysfunction, vesicoureteral reflux and patterns of urinary tract infection in children.
    Storm DW; Patel AS; Horvath DJ; Li B; Koff SA; Justice SS
    J Urol; 2012 Jul; 188(1):236-41. PubMed ID: 22595065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic acidosis exacerbates pyelonephritis in mice prone to vesicoureteral reflux.
    Purkerson JM; Corley JL; Schwartz GJ
    Physiol Rep; 2020 Oct; 8(19):e14525. PubMed ID: 33030238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a long-term ascending urinary tract infection mouse model for antibiotic treatment studies.
    Hvidberg H; Struve C; Krogfelt KA; Christensen N; Rasmussen SN; Frimodt-Møller N
    Antimicrob Agents Chemother; 2000 Jan; 44(1):156-63. PubMed ID: 10602738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of significance of pili in experimental ascending Escherichia coli pyelonephritis.
    Guze LB; Silverblatt F; Montgomerie JZ; Ishida K; Kalmanson GM
    Scand J Infect Dis; 1983; 15(1):57-64. PubMed ID: 6133346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of type 1 pili and effects of phase variation on lower urinary tract infections produced by Escherichia coli.
    Hultgren SJ; Porter TN; Schaeffer AJ; Duncan JL
    Infect Immun; 1985 Nov; 50(2):370-7. PubMed ID: 2865209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An ascending non-obstructive model for chronic pyelonephritis in BALB/c mice.
    Gupta R; Ganguly NK; Ahuja V; Joshi K; Sharma S
    J Med Microbiol; 1995 Jul; 43(1):33-6. PubMed ID: 7608952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of type 1 pilus expression in Escherichia coli to ascending urinary tract infections in mice.
    Schaeffer AJ; Schwan WR; Hultgren SJ; Duncan JL
    Infect Immun; 1987 Feb; 55(2):373-80. PubMed ID: 2879794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of P blood group, vesicoureteral reflux, and bacterial attachment in patients with recurrent pyelonephritis.
    Lomberg H; Hanson LA; Jacobsson B; Jodal U; Leffler H; Edén CS
    N Engl J Med; 1983 May; 308(20):1189-92. PubMed ID: 6341837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.